Arkolith/Insider Trading/RCUS/Form 4

Gilead Sciences, Inc.

10% OwnerArcus Biosciences, Inc. (RCUS) · full profile →Form 4 · filed Feb 20, 2025
Net Buying
Open-Market Buys
$15.0M
Open-Market Sells
$0
Net Open-Market Flow
$15.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2025Buy(P)1.4M$11.00$15.0M31.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-003084) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML